StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.64−0.00 (-0.73%)

Close on Oct 19, 2026Market cap $522.65KP/E –Yield –

Nexentis Technologies free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Nexentis Technologies's free cash flow for the twelve months ending Dec 31, 2022 was -$5.15M. For fiscal 2025 it was -$3.82M. The highest annual figure on record is -$509.03K in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.82M–
FY2022Dec 31, 2022-$5.15M–
FY2021Dec 31, 2021-$4.18M–
FY2019Dec 31, 2019-$1.27M–
FY2018Dec 31, 2018-$509.03K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$540.00K–
Q1 FY2026Mar 31, 2026-$1.49M–
Q4 FY2022Dec 31, 2022-$974.52K–
Q3 FY2022Sep 30, 2022-$1.79M–
Q2 FY2022Jun 30, 2022-$1.28M–
Q1 FY2022Mar 31, 2022-$1.10M–
Q4 FY2021Dec 31, 2021-$975.79K–
Q4 FY2019Dec 31, 2019-$383.40K–

More Nexentis Technologies figures

See a number that looks wrong?